Syndax Pharmaceuticals (SNDX) EBT Margin Growth (3y) (2018 - 2024)
Syndax Pharmaceuticals (SNDX) EBT Margin Growth (3y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -130,103.00 |
| Sep 30, 2024 | -50,682.00 |
| Jun 30, 2024 | 391,250.00 |
| Dec 31, 2021 | 469,769.00 |
| Sep 30, 2021 | 453,672.00 |
| Jun 30, 2021 | -106,702.00 |
| Mar 31, 2021 | -203,931.00 |
| Dec 31, 2020 | -347,055.00 |
| Sep 30, 2020 | -28,664.00 |
| Jun 30, 2020 | 564.00 |
| Mar 31, 2020 | 25,691.00 |
| Dec 31, 2019 | 27,752.00 |
| Sep 30, 2019 | 124,334.00 |
| Jun 30, 2019 | -154,579.00 |
| Mar 31, 2019 | -113,156.00 |
| Dec 31, 2018 | -306,040.00 |
| Sep 30, 2018 | -271,825.00 |
| Jun 30, 2018 | 2.89 Mn |